Use of GLP-1 or Analogs in Treatment of Stroke

Details for Australian Patent Application No. 2003270960 (hide)

Owner Eli Lilly and Company

Inventors Efendic, Suad

Agent Wrays

Pub. Number AU-B-2003270960

Parent 766375

Filing date 17 December 2003

Wipo publication date 22 January 2004

Acceptance publication date 21 December 2006

International Classifications

A61K 38/26 (2006.01) Medicinal preparations containing peptides - Glucagons

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

15 January 2004 Complete Application Filed

22 January 2004 Application Open to Public Inspection

  Published as AU-B-2003270960

21 December 2006 Application Accepted

  Published as AU-B-2003270960

7 June 2007 Standard Patent Sealed

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003270961-Rotatory crank shaft

2003270959-Identifier label application system